e-learning
resources
Milan 2017
Sunday, 10.09.2017
Systemic and airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes.
G. Scioscia (Lucera, FG, Italy)
Source:
International Congress 2017 – Systemic and airway biomarkers
Session:
Systemic and airway biomarkers
Session type:
Thematic Poster
Number:
1017
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Scioscia (Lucera, FG, Italy). Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes.. 1017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath
Source: ERS Lung Science Conference 2016
Year: 2016
Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases
Source: Annual Congress 2009 - Lung function in adults and children
Year: 2009
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004
Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008
Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006
Metabonomics applied to exhaled breath condensate in childhood asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 123s
Year: 2006
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 438s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept